Menu
ncarol.com
  • Home
  • Books
  • Health
  • Book Release
  • Manufacturing
  • Real Estate
  • Business
  • Financial
  • Education
ncarol.com

EduCare Announces NEW Recurrent and Metastatic Breast Cancer Treatment Handbook
ncarol.com/10031812

Trending...
  • 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
  • New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors
  • Free Commercial Glass Estimating and Code Compliance Tools Launched by Landmark Construction - The Leading Glass Company in Los Angeles
Recurrent and Metastatic Breast Cancer Treatment Handbook EduCare
The 1st Edition of the Recurrent and Metastatic Breast Cancer Treatment Handbook is now available. This book is designed to educate women about treatments for recurrent and metastatic breast cancer, while also addressing the emotions that come with this diagnosis.

CHARLESTON, S.C. - ncarol.com -- For years, recurrent and metastatic breast cancer patients have often felt overlooked. Metastatic breast cancer patients live each day with an incurable disease and must face ongoing treatment regimens as well as intense physical, psychological and emotional issues. Author, Judy C. Kneece, RN, OCN, is excited to release the new Recurrent and Metastatic Breast Cancer Treatment Handbook. She wrote this book to not only educate women about treatments for recurrent and metastatic breast cancer, but just as importantly, she writes about the personal side – the fears, the sorrows, the pain and the choices a woman faces after hearing her diagnosis.

Judy C. Kneece, RN, OCN, states, "This book is about helping you, a recurrent or metastatic patient, take charge of decisions about your life. It offers no guarantees, but it does promise you can live your life fully while dealing with recurrent/metastatic breast cancer if you decide to. You choose what actions you will take – you can make no mistakes. In this area, you are the expert." Her goal is to provide a woman the tools she needs to live her life to the fullest, while fighting this battle.

More on ncarol.com
  • RemoteBridge Names Dr. John N. Just, Ed.D. Chief Executive Officer
  • Project CIVICA Report Finds 10,680 Non-Citizen Indicators on New York Voter Rolls — Including 88 Records with Recent Voting History
  • New Analysis Details Three Converging Forces in AI and Workforce Policy Behind a $37 Billion GDP Reduction
  • Revenue Optics Launches Pricing and Revenue Growth Management Practice, Names Shafohi Alamgir Vice President
  • Popular AI planner Voiset launches version 2.0 and enters MENA at LEAP 2026 with full Arabic support

Based on the premise that well-informed patients make the best patients, the Recurrent and Metastatic Breast Cancer Treatment Handbook covers cancer treatment (types of recurrence, treatment decisions, second opinions, surgical options, reconstruction options, treatment medications and radiation therapy), emotional issues (facing anxiety and depression, helping children cope, communicating with the healthcare team, creating a support team, facing death) and ongoing treatment issues (pain management, insurance, diet and exercise, sexuality problems). The book also has a comprehensive appendix that explains diagnostic tests, chemotherapy drugs and clinical trials.

In her review of the book, Beth Baughman DuPree, MD, FACS, ABOIM wrote, "This handbook will help you navigate the medical, emotional and spiritual challenges you are about to face. Metastatic breast cancer is a 'chronic disease' and there is no way to know what path your cancer journey will follow. Releasing fear and finding peace allows each moment of your life to be savored and appreciated. This is an invaluable guide for every woman facing a metastatic breast cancer diagnosis."

More on ncarol.com
  • CasaPerks and CredHub Partner to Help the Multifamily Industry Strengthen Resident Activation Through Credit-Building Rewards
  • NaturismRE expands international research programme with Health & Wellbeing Survey
  • L2 Aviation and Gotonomi Extend UAV Connectivity Beyond Cellular Reach
  • Re:InvestorHub Launches the First AI-Powered Operating System Built for Real Estate Investors
  • Nadi Plumbing Leads Charlotte in Private Fire Hydrant Services, Eyes Regional Expansion

EduCare Inc., a dedicated breast health education company, was founded in January 1994 by Judy C. Kneece, RN, OCN. For more than 25 years, EduCare has been a leader in providing the highest quality breast health educational materials for patients and healthcare providers and in offering continuing training to healthcare professionals.

The Recurrent and Metastatic Breast Cancer Treatment Handbook may be purchased directly through EduCare at www.EduCareInc.com or by phone at 843.760.6064.  It is also available on Amazon.

Media Contact
Mindy Wilson
***@educareinc.com
843-760-6064


Source: EduCare Publishing Inc.
Filed Under: Books, Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
  • STEM For Kids® Unveil Turn-Key "Screen-Smart" Solution to Bridge Teacher Preparedness Gaps in Texas
  • Award-Winning Couture Master Perfumer JoAnne Bassett Launches All-Natural DIY Perfume Making Kits
  • Couture Master Perfumer JoAnne Bassett Offers Rare Opportunity to Acquire 70 Formula Perfume Codex
  • Slotozilla Reports Strong Growth in Q2 2026
  • Flexible Plan Investments Names Carl Resnick President
  • Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety
  • Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd
  • No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
  • The Refugee Archive Launches Campaign to Preserve 21 Female-Headed Household Oral Histories in Rebel-Controlled Goma
  • Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
  • FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Buy Retatrutide Research Peptide: Why Reta Is Getting So Much Attention
  • New Book Helps Educators Navigate AI in the Classroom While Keeping Humans in Charge
  • San Diego Attorney Anthony Z. Vargas Narrows Practice to Employment Law, Representing Employees Only
  • LifeTime Asset & Tax Management Named on the 2026 Inc. 5000 List
  • Solid Earth Introduces RealtyID, a Universal Identity Spine for the Real Estate Industry
  • Pastor Miguel Bustillos Brings Deliverance and Exorcism Ministry Conference to Durham, NC
  • TOLI CORPORATION's President Visits U.S. to Celebrate Partnerships and Support North American Market
  • BumbleBeeSmart Launches Dedicated Sensory Wall Panels Collection for Adults, Memory Care and Senior Living
_catLbl0 _catLbl1

Popular on ncarol.com

  • Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 315
  • Omnitronics launches Ecosystem Health Dashboard to enable proactive monitoring across dispatch environments - 138
  • Why Baton Rouge's Humid Climate Can Contribute to Carpenter Ant Damage — J&J Exterminating Explains How to Protect Your Home - 121
  • $620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC) - 120
  • Opteamix welcomes Girish Ramachandra to its leadership team as Senior Vice President of Client Services - 110
  • New Research Identifies "The Great Junk Transfer": 49% of Americans Would Rather Inherit Nothing Than Sort Through a Relative's Belongings - 106
  • RAS AP Consulting Expands Managed AP Governance™ Ecosystem, Launches Trademark Process, and Secures IFOL Speaker Invitation - 105
  • UK Financial Ltd Verifies Maya Preferred PRA Circulating Supply, Proving Its Eight-Year Promise of Under 1M Tokens After Chainlink Labs Agreement - 102
  • 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne - 101
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism

Similar on ncarol.com

  • When the Coroner's Report Isn't Enough: Colorado Families Turn to Private Autopsy for Closure
  • NaturismRE expands international research programme with Health & Wellbeing Survey
  • Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man
  • The Sharon at SouthPark Breaks Ground on $178 Million Expansion
  • Independent Colbert Packaging Thrives Amid Industrywide Consolidation
  • Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
  • Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety
  • No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
  • FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Buy Retatrutide Research Peptide: Why Reta Is Getting So Much Attention
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute